Sulfonylurea Compounds

Known as: Compounds, Sulfonylurea, sulphonylurea, sulphonylureas 
 
National Institutes of Health

Related topics

Related topics

48 relations

Narrower (32)

4-dextran-sulfonylurea-piretanideAHR 12234BM 27BM 531
(More)

Broader (3)

AntidiabeticsHypoglycemic AgentsSulfonamides
GlyburideIn BloodSulfonylurea [EPC]Sulfonylurea:PrThr:Pt:Ser/Plas:Ord
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Early Glycaemic Control in Metformin Users Receiving Their First Add-On Therapy: A Population-Based Study of 4,734 People with… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
The aim of the study was to compare the efficacy and safety of liraglutide in type 2 diabetes mellitus vs placebo and insulin… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
OBJECTIVE Numerous studies have identified an increased risk of cancer in type 2 diabetes. We explored the association between… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
BACKGROUND Heterozygous activating mutations in KCNJ11, encoding the Kir6.2 subunit of the ATP-sensitive potassium (K(ATP… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.
OBJECTIVE This study evaluated the effects of exenatide, a novel incretin mimetic, in hyperglycemic patients with type 2 diabetes… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.
OBJECTIVE This study evaluated the ability of the incretin mimetic exenatide (exendin-4) to improve glycemic control in patients… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Sulfonylurea-resistant mutants of Arabidopsis thaliana
Chlorsulfuron-resistant mutants of Arabidopsis thaliana were isolated by screening for growth of seedlings in the presence of the… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study…
CONTEXT Treatment with diet alone, insulin, sulfonylurea, or metformin is known to improve glycemia in patients with type 2… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
BACKGROUND Improved blood-glucose control decreases the progression of diabetic microvascular disease, but the effect on… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
Sulfonylureas are a class of drugs widely used to promote insulin secretion in the treatment of non-insulin-dependent diabetes… (More)
Is this relevant?